subscribeSubscribe
Eugia Pharma Generic Tirofiban Hydrochloride Receives Approval in the U.S

Eugia Pharma Generic Tirofiban Hydrochloride Receives Approval in the U.S
FDA
01 May 2023
Share Share
Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN®

Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN®
PRNEWSWIRE
04 Nov 2021
Share Share
Medicure Announces Early Completion of Enrollment for Ispasm

Medicure Announces Early Completion of Enrollment for Ispasm
PRNEWSWIRE
28 Jan 2021
Share Share
MEDICURE ANNOUNCES EARLY COMPLETION OF ENROLLMENT FOR ISPASM, A PHASE 1/2A

MEDICURE ANNOUNCES EARLY COMPLETION OF ENROLLMENT FOR ISPASM, A PHASE 1/2A
MEDICURE
28 Jan 2021
Share Share
Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications

Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications
PRNEWSWIRE
24 Aug 2020
Share Share
Correvio partners with Teson for commercializing cardiac drug in China

Correvio partners with Teson for commercializing cardiac drug in China
BIOSPECTRUMASIA
11 Mar 2020
Share Share
Medicure Files Patent Infringement Action

Medicure Files Patent Infringement Action
PR NEWSWIRE
05 Dec 2019
Share Share
FDA Confirms Paragraph IV Patent Challenge ofAggrastat 20913(Tirofiban) Hydrochloride Injection 12.5 mg/250 Ml & 5 mg/100 mL

FDA Confirms Paragraph IV Patent Challenge ofAggrastat 20913(Tirofiban) Hydrochloride Injection 12.5 mg/250 Ml & 5 mg/100 mL
FDA
11 Oct 2019
Share Share
Medicure Files Patent Infringement Action

Medicure Files Patent Infringement Action
PR NEWSWIRE
16 Nov 2018
Share Share
Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome
PR NEWSWIRE
15 Apr 2018
Share Share